Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2011; 17(35): 4007-4012
Published online Sep 21, 2011. doi: 10.3748/wjg.v17.i35.4007
Published online Sep 21, 2011. doi: 10.3748/wjg.v17.i35.4007
D1 | D2 | P value | |
Gender | |||
M | 61 (63.5) | 71 (59.2) | 0.512 |
F | 35 (36.5) | 49 (40.8) | |
Age (yr) | |||
< 70 | 70 (72.9) | 86 (71.7) | 0.142 |
≥ 70 | 26 (27.1) | 34 (28.3) | |
Surgical Procedure | |||
TG | 79 (82.3) | 55 (45.8) | 0.001 |
DSG | 17 (17.7) | 65 (54.2) | |
Anatomical localization of primary tumor | |||
Proximal | 9 (9.4) | 9 (7.5) | 0.087 |
Middle | 39 (40.6) | 43 (35.8) | |
Distal | 33 (34.4) | 59 (49.2) | |
Diffuse | 15 (15.6) | 9 (7.5) | |
Number of lymph nodes removed (mean ± SD) | 14.4 ± 6.1 | 23.5 ± 9.3 | 0.022 |
Number of metastatic lymph nodes (mean ± SD) | 3.8 ± 2.2 | 6.1 ± 4.6 | 0.034 |
T (Depth of invasion) | |||
T1 | 8 (8.3) | 9 (7.5) | 0.056 |
T2 | 9 (9.4) | 15 (12.5) | |
T3 | 59 (61.5) | 75 (62.5) | |
T4 | 20 (20.8) | 21 (17.5) | |
N (According to AJCC) | |||
0 | 20 (20.8) | 26 (21.7) | 0.296 |
1 | 32 (33.3) | 47 (39.2) | |
2 | 40 (41.7) | 37 (30.8) | |
3 | 4 (4.2) | 10 (8.3) | |
TNM stage | |||
IA | 2 (2.1) | 6 (5.0) | 0.001 |
IB | 12 (12.5) | 7 (5.8) | |
II | 19 (19.8) | 30 (25) | |
IIIA | 42 (43.8) | 58 (48.3) | |
IIIB | 21 (21.9) | 19 (15.8) | |
V | - | - | |
Pathology | |||
Adenocarcinoma | 77 (80.2) | 97 80.8) | NA |
Signet ring cell | 4 (4.2) | 18 (15.0) | |
MAC | 10 (10.4) | 2 (1.7) | |
Carcinoid tumor | 2 (2.1) | - | |
Lymphoma | 3 (3.1) | 3 (2.5) | |
N ratio | |||
0 | 12 (12.5) | 19 (15.8) | 0.001 |
1 | 29 (30.2) | 34 (28.3) | |
2 | 39 (40.6.) | 23 (19.2) | |
3 | 16 (16.7) | 44 (36.7) | |
Lauren classification | |||
Diffuse | 47 (49.0) | 52 (53.3) | 0.424 |
Intestinal | 49 (51.0) | 68 (56.7) |
N | D | n | 5 YS | P value | N ratio | n | 5 YS | P value |
N0 | D1 | 20 | 6 (30.0%) | 0.172 | 0 | 20 | 6 (30.0%) | 0.389 |
D2 | 26 | 13 (50.0%) | 26 | 13 (50.0%) | ||||
N1 | D1 | 32 | 4 (12.5%) | 0.047 | 1 | 29 | 4 (13.8%) | 0.070 |
D2 | 47 | 15 (31.9%) | 44 | 13 (29.5%) | ||||
N2 | D1 | 40 | 6 (15.0%) | 0.044 | 2 | 39 | 5 (12.8%) | 0.192 |
D2 | 37 | 1 (2.7%) | 32 | 3 (9.4%) | ||||
N3 | D1 | 4 | NA | NA | 3 | 16 | 1 (6.3%) | 0.267 |
D2 | 10 | NA | 44 | 0 |
N ratio (metastatic/total number of lymph nodes removed) | |||||
0(0) | 1(0-9) | 2(10-25) | 3(> 25) | Total | |
D1 group | |||||
N0 (0) | 20 (100) | 20 | |||
N1 (1-6) | 21 (65.6) | 11 (34.4) | 32 | ||
N2 (7-15) | 28 (70.0) | 12 (30.0) | 40 | ||
N3 (> 15) | 4 (100) | 4 | |||
D2 group | |||||
N0 (0) | 26 (100) | 26 | |||
N1 (1-6) | 37 (78.7) | 6 (12.8) | 4 (8.5) | 47 | |
N2 (7-15) | 26 (70.3) | 11 (29.7) | 37 | ||
N3 (> 15) | 10 (100) | 10 |
- Citation: Sakcak I, Yıldız BD, Avşar FM, Akturan S, Kilic K, Cosgun E, Hamamci EO. Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer? World J Gastroenterol 2011; 17(35): 4007-4012
- URL: https://www.wjgnet.com/1007-9327/full/v17/i35/4007.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i35.4007